- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01628705
Moderated-fat Diet Complemented With Green Tea Reduces oxLDL and Fat Mass in Obese Women (GTRoxLDL)
Moderated-fat Diet Complemented With Green Tea Reduces oxLDL and Fat Mass in Obese Women: A Randomized, Controlled Clinical Trial
Background: Obesity is a chronic degenerative disease, considered as cardiovascular risk factor, characterized by systemic inflammation and high levels of oxLDL. Clinical studies have suggested that drink green tea could improve these complications.
Objective: Analyze the effect of a moderate-fat diet complemented with green tea on oxLDL, fat mass and TNFa in obese women.
Design: Randomized, controlled clinical trial. Obese women, without other chronic-degenerative disease were divided using a computer-generated random sequence: control group (CON) with n=32, and intervention group (INT) with n=32; and were instructed to consume a moderate-fat diet, and INT group was instructed to complement the diet with green tea. Anthropometric and biochemical measurements were performed, and oxLDL and TNFa s levels were determined by ELISA. All parameters were realized at baseline and in the 1st, 2nd and 3rd months post-intervention. TNFa mRNA expression was determined by real-time RT-PCR (basal and final). The changes on lipid profile, oxLDL, fat mass and TNFalpha expression were reported of the comparison between basal and final time points. The statistical analysis was performed with SPSS software.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Jaliscco
-
Guadalajara, Jaliscco, Mexico, 44280
- University of Guadalajara
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- obese women older than 18 years,
- in good health, as determined by a medical history questionnaire, and
- normal results of clinical laboratory tests excluding lipids
Exclusion Criteria:
- history of cardiovascular, hepatic, gastrointestinal, or renal disease;
- no alcoholism, no smoking, no exogenous hormone use or other medication;
- no supplemental vitamin or infusion drinking (tea, coffee); or
- treatment for weight loss 3 months before the start of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Nutritional intervention
The subjects were undergoing nutritional intervention.
|
The subjects were undergoing nutritional intervention was reduced by 500 kcal per day of habitual caloric intake. The proportion of daily intake of macronutrient in the moderate-fat diet was: 30% fat (saturated fat <7%, monounsaturated 10-15% and polyunsaturated 10%, respectively to total calories), 15% of protein, and 55% of carbohydrates. The dietary cholesterol was less than 200 mg/day, fiber intake was increased to 25 grams per day (50% soluble fiber). |
Experimental: Nutritional intervention with green tea
The subjects were undergoing nutritional intervention complemented with green tea.
|
The patients drank secha green tea.
Subjects of the INT group were instructed on how to prepare the green tea infusion.
Each cup was prepared using 3g of dried green tea in 300ml of hot water (temperature 80°C)for 4 min.
It was drunk fresh and without sugar.
The treatment consisted of 2 cup/day of green tea, one in the morning and one at night.
The amount of epigallocathechin-3-gallate was 498mg/day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in low density cholesterol
Time Frame: Change from baseline in lipids, fat mass and TNF aplha levels at 3 months.
|
Change in low density cholesterol, change in high density cholesterol, change in triglycerides, change in oxLDL and change in fat mass were assessed at the beginning and at each month during 3 months of intervention.
Change in TNF alpha levels was assessed at the beginning and after 3 months.
The final changes of all the measures were reported of the comparation between basal and after 3 months.
|
Change from baseline in lipids, fat mass and TNF aplha levels at 3 months.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change in high density cholesterol
Time Frame: baseline, 3 months
|
baseline, 3 months
|
change in triglycerides
Time Frame: baseline, 3 months
|
baseline, 3 months
|
change in oxLDL
Time Frame: baseline, 3 months
|
baseline, 3 months
|
change in fat mass
Time Frame: baseline, 3 months
|
baseline, 3 months
|
change in TNF alpha levels
Time Frame: baseline, 3 months
|
baseline, 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: ERIKA MARTINEZ-LOPEZ, PhD, University of Guadalajara
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CI-10808
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nutritional and Metabolic Disease
-
Centro de Investigación en Alimentación y Desarrollo...Universidad de SonoraCompletedNutritional and Metabolic Disease
-
Hadassah Medical OrganizationRecruitingSedentary Behavior | Nutritional and Metabolic DiseaseIsrael
-
Physicians Committee for Responsible MedicineCompletedDietary Modification | Nutritional and Metabolic DiseaseUnited States
-
Clinical Nutrition Research Center, Illinois Institute...California Strawberry CommissionCompletedInsulin Resistance | Metabolic Disease | Nutritional DiseaseUnited States
-
Isfahan University of Medical SciencesCompletedNutritional and Metabolic DiseaseIran, Islamic Republic of
-
Yonsei UniversityUnknownCardiovascular Disease | Metabolic DiseaseKorea, Republic of
-
Clinical Nutrition Research Centre, SingaporeCompletedCardiovascular Disease | Metabolic Disease
-
Clinical Nutrition Research Center, Illinois Institute...GlaxoSmithKlineCompletedOverweight | Nutritional and Metabolic DiseaseUnited States
-
University Hospitals Coventry and Warwickshire...University of WarwickNot yet recruiting
-
University Hospital, LilleRecruiting
Clinical Trials on Nutritional intervention
-
Clinica Universidad de Navarra, Universidad de...Recruiting
-
China-Japan Friendship HospitalRecruiting
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedObesity | OverweightUnited States
-
Gødstrup HospitalDanish Cancer SocietyNot yet recruitingCancer | Malnutrition | Nutritional InterventionDenmark
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Laval UniversityRecruitingPregnancy Complications | Gestational DiabetesCanada
-
Johannes Gutenberg University MainzGoethe UniversityCompletedDiabetes Mellitus, Type 2 | Hyperlipidemias | NASH - Nonalcoholic SteatohepatitisGermany
-
Hospices Civils de LyonCompleted
-
University of ZurichCompletedHealthy ControlsSwitzerland